In Washington, researchers used blood from a National Children’s Study biobank to identify more accurate reference intervals for various hormones and amino acids in newborns across a diverse population. The more defined reference intervals could help with earlier diagnosis of diseases like diabetes and pediatric cancer as well as lead to a better understanding of physical and neurological development. As we know, newborns are tiny and its often difficult to draw a significant amount of blood from them for testing, which has proven to be a challenge in the past for researchers to have enough blood to test and reference. The hope is with this research, doctors will have a more accurate reference interval to refer to when testing pediatric patients for developmental issues or diseases.
Latest article
Jurassic couture: Partnership looks to use T-Rex DNA to create dino leather handbags
In the Netherlands, a consortium of companies is looking to grow material similar to that of T-Rex skin to create a truly unique leather...
Chick-fil-A’s lemon waste eyed for bioplastics
In California, waste from Chick-fil-A’s lemon juice supplier could one day be used to produce bioplastics.
Bay Center Foods, which provides all of the...
Greek Startup Coffeeco Raises 715K Euros
In Greece, Coffeeco Upgrade SA, a company converting coffee waste into products like makeup and bioplastics, has raised €715,000 in the first close of...